TechniScan, Inc. (OTC Bulletin Board: TSNI) ("TechniScan" or the "Company"), a medical device company engaged in the development and commercialization of an automated 3-D breast ultrasound imaging system, today announced that in collaboration with University Medical Center Freiburg in Germany, it has launched a clinical study to assess clinical utility of TechniScan's Warm Bath Ultrasound.
TechniScan's Warm Bath Ultrasound (WBU™) system is designed for state-of-the-art ultrasound technology, used in a warm water tank, to capture 3-D images of the breast as a woman lies prone on a table.
The University Medical Center Freiburg was founded in 1457 and is one of the most prestigious and reputable hospitals in Europe due to its extensive clinical capabilities and advances in medical research. The Breast Examination Center of the Radiology Department, University Medical Center Freiburg is a regional center for women's health and it is the ideal place for the study.
Clinicians will scan a total of at least 150 women within three defined groups: Those with normal mammography findings, those with known benign lesions, and those with known malignancies. The study includes direct comparison of TechniScan's WBU™ images against mammogram, MRI and hand held ultrasound to directly evaluate the ability of WBU™ in providing comparative diagnostic findings.